• 3499 Citations
  • 31 Scopus h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where James L Slack is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 23 Similar Profiles
Acute Promyelocytic Leukemia Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Tretinoin Medicine & Life Sciences
decitabine Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1990 2001

Acute Promyelocytic Leukemia
Acute Myeloid Leukemia
Tretinoin
Genes
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
Gene Expression
Genes
Collagen
Oncogenes
Trans-Activators

Research Output 1990 2019

  • 3499 Citations
  • 31 Scopus h-Index
  • 58 Article
  • 1 Chapter
  • 1 Letter

Clonal analyses of refractory testicular germ cell tumors

Barrett, M., Lenkiewicz, E., Malasi, S., Stanton, M., Slack, J. L., Andrews, P., Pagliaro, L. & Bryce, A. H., Mar 1 2019, In : PloS one. 14, 3, e0213815.

Research output: Contribution to journalArticle

Open Access
Refractory materials
Tumors
germ cells
Cells
neoplasms

Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?

Jain, T., Kunze, K. L., Khetarpal, B. K., McCallen, M. R., Betcher, J. A., Ofori, H. T., Khera, N. D., Slack, J. L., Leis, J. F., Sproat, L., Noel, P. & Palmer, J., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Busulfan
Stem Cell Transplantation
Area Under Curve
Hepatic Veno-Occlusive Disease
Therapeutics
7 Citations (Scopus)
Primary Myelofibrosis
Hematopoietic Stem Cells
Karyotype
Transplants
Survival
5 Citations (Scopus)

Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

Jain, T., Kunze, K. L., Temkit, M., Partain, D. K., Patnaik, M. M., Slack, J. L., Khera, N. D., Hogan, W., Roy, V., Noel, P., Leis, J. F., Sproat, L., Fauble, V., Mesa, R. A. & Palmer, J., May 24 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-8 8 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Hematopoietic Stem Cell Transplantation
Melphalan
Busulfan
Chimerism
118 Citations (Scopus)

Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML

DiNardo, C. D., Stein, E. M., De Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Swords, R., Collins, R. H., Mannis, G. N., Pollyea, D. A., Donnellan, W., Fathi, A. T., Pigneux, A., Erba, H. P., Prince, G. T., Stein, A. S., Uy, G. L., Foran, J. M., Traer, E., Stuart, R. K. & 20 others, Arellano, M. L., Slack, J. L., Sekeres, M. A., Willekens, C., Choe, S., Wang, H., Zhang, V., Yen, K. E., Kapsalis, S. M., Yang, H., Dai, D., Fan, B., Goldwasser, M., Liu, H., Agresta, S., Wu, B., Attar, E. C., Tallman, M. S., Stone, R. M. & Kantarjian, H. M., Jun 21 2018, In : New England Journal of Medicine. 378, 25, p. 2386-2398 13 p.

Research output: Contribution to journalArticle

Isocitrate Dehydrogenase
Acute Myeloid Leukemia
Confidence Intervals
Mutation
Safety